ARG1 and neoplasm: The accumulation of ARG1-expressing immunomodulatory cells, including M2-like tumor-associated macrophages, tolerogenic DCs, MDSCs, and Treg cells, in the tumor microenvironment (TME) may suppress antitumor immunity by degrading arginine, thus limiting the availability of this amino acid to T cells (96, 97).